BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37344825)

  • 1. Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.
    Ruan P; Todd JL; Zhao H; Liu Y; Vinisko R; Soellner JF; Schmid R; Kaner RJ; Luckhardt TR; Neely ML; Noth I; Porteous M; Raj R; Safdar Z; Strek ME; Hesslinger C; Palmer SM; Leonard TB; Salisbury ML
    Respir Res; 2023 May; 24(1):141. PubMed ID: 37344825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.
    Todd JL; Neely ML; Overton R; Durham K; Gulati M; Huang H; Roman J; Newby LK; Flaherty KR; Vinisko R; Liu Y; Roy J; Schmid R; Strobel B; Hesslinger C; Leonard TB; Noth I; Belperio JA; Palmer SM;
    Respir Res; 2019 Oct; 20(1):227. PubMed ID: 31640794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry.
    Swaminathan AC; Hellkamp AS; Neely ML; Bender S; Paoletti L; White ES; Palmer SM; Whelan TPM; Dilling DF;
    Ann Am Thorac Soc; 2022 Jun; 19(6):981-990. PubMed ID: 35073248
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
    Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
    Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
    Oldham JM; Huang Y; Bose S; Ma SF; Kim JS; Schwab A; Ting C; Mou K; Lee CT; Adegunsoye A; Ghodrati S; Pugashetti JV; Nazemi N; Strek ME; Linderholm AL; Chen CH; Murray S; Zemans RL; Flaherty KR; Martinez FJ; Noth I
    Am J Respir Crit Care Med; 2024 May; 209(9):1111-1120. PubMed ID: 37847691
    [No Abstract]   [Full Text] [Related]  

  • 7. Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis.
    Kraven LM; Taylor AR; Molyneaux PL; Maher TM; McDonough JE; Mura M; Yang IV; Schwartz DA; Huang Y; Noth I; Ma SF; Yeo AJ; Fahy WA; Jenkins RG; Wain LV
    Thorax; 2023 Jun; 78(6):551-558. PubMed ID: 35534152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for airways biomarkers useful to identify progressive pulmonary fibrosis.
    Soccio P; Moriondo G; Scioscia G; Leo V; Tondo P; Salerno L; Palange P; Barbaro MPF; Lacedonia D
    BMC Pulm Med; 2023 Oct; 23(1):407. PubMed ID: 37884953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.
    Herazo-Maya JD; Sun J; Molyneaux PL; Li Q; Villalba JA; Tzouvelekis A; Lynn H; Juan-Guardela BM; Risquez C; Osorio JC; Yan X; Michel G; Aurelien N; Lindell KO; Klesen MJ; Moffatt MF; Cookson WO; Zhang Y; Garcia JGN; Noth I; Prasse A; Bar-Joseph Z; Gibson KF; Zhao H; Herzog EL; Rosas IO; Maher TM; Kaminski N
    Lancet Respir Med; 2017 Nov; 5(11):857-868. PubMed ID: 28942086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis.
    Kim SK; Jung SM; Park KS; Kim KJ
    BMC Pulm Med; 2021 Dec; 21(1):404. PubMed ID: 34876074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosis.
    Zheng P; Sun S; Wang J; Cheng ZJ; Lei KC; Xue M; Zhang T; Huang H; Zhang XD; Sun B
    Cell Mol Life Sci; 2022 Jan; 79(1):66. PubMed ID: 35015148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.
    Wang Y; Yella J; Chen J; McCormack FX; Madala SK; Jegga AG
    BMC Pulm Med; 2017 Oct; 17(1):133. PubMed ID: 29058630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA and protein-coding gene expression analysis in idiopathic pulmonary fibrosis yields novel biomarker signatures associated to survival.
    Casanova NG; Zhou T; Gonzalez-Garay ML; Lussier YA; Sweiss N; Ma SF; Noth I; Knox KS; Garcia JGN
    Transl Res; 2021 Feb; 228():1-12. PubMed ID: 32711186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry.
    Gao J; Kalafatis D; Carlson L; Pesonen IHA; Li CX; Wheelock Å; Magnusson JM; Sköld CM
    Respir Res; 2021 Feb; 22(1):40. PubMed ID: 33546682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis.
    Zhao T; Wu X; Zhao X; Yao K; Li X; Ni J
    Front Immunol; 2023; 14():1159856. PubMed ID: 37122736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Signatures of Idiopathic Pulmonary Fibrosis.
    Konigsberg IR; Borie R; Walts AD; Cardwell J; Rojas M; Metzger F; Hauck SM; Fingerlin TE; Yang IV; Schwartz DA
    Am J Respir Cell Mol Biol; 2021 Oct; 65(4):430-441. PubMed ID: 34038697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.
    Snyder L; Neely ML; Hellkamp AS; O'Brien E; de Andrade J; Conoscenti CS; Leonard T; Bender S; Gulati M; Culver DA; Kaner RJ; Palmer S; Kim HJ;
    Respir Res; 2019 May; 20(1):105. PubMed ID: 31142314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis involved in human idiopathic pulmonary fibrosis based on an integrated microRNA‑mRNA interaction network.
    Wang L; Huang W; Zhang L; Chen Q; Zhao H
    Mol Med Rep; 2018 Nov; 18(5):4365-4373. PubMed ID: 30221703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis.
    Adegunsoye A; Alqalyoobi S; Linderholm A; Bowman WS; Lee CT; Pugashetti JV; Sarma N; Ma SF; Haczku A; Sperling A; Strek ME; Noth I; Oldham JM
    Chest; 2020 Oct; 158(4):1526-1534. PubMed ID: 32450241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis.
    McDonough JE; Kaminski N; Thienpont B; Hogg JC; Vanaudenaerde BM; Wuyts WA
    Thorax; 2019 Feb; 74(2):132-140. PubMed ID: 30366970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.